A recent study by Yale researchers found that Borrelia burgdorferi, the causative agent of Lyme disease, exhibits a unique pattern of cell growth, elongating through discrete “hot zones” of cell wall synthesis that mark where daughter cells will divide. This discovery could help yield new, targeted therapies for Lyme disease.
“Bridgmanite” is hardly a household name. And yet, bridgmanite is likely the most abundant mineral on Earth, composing much of the mantle, the thickest layer of our planet. This mineral may provide clues into how the solid Earth—and its atmosphere—has evolved over its long history.
One of the oldest cold cases in history is the death of Lucy, the 3.2-million-year-old hominin. John Kappelman, who completed his undergraduate training at Yale, did some detective work on Lucy’s skeleton; an analysis of her bone fractures revealed that she may have died from falling out of a tree.
Yale professor of chemistry David Spiegel and his company Kleo Pharmaceuticals are working to develop drug platforms that could be revolutionary immunotherapies for treating cancer and infectious diseases. “Kleo” is a synthesis of the names of Spiegel’s wife and son.
Five weeks after launch, the highly anticipated X-ray satellite Hitomi disintegrated. As researchers look towards future missions, they will use key insights from Hitomi to construct more robust satellites.
Rather than speculate on how organisms evolved certain adaptations, scientists are attempting to recreate some of these historic transitions—such as the development of fins into feet—in the lab.
In collaboration with the physicists from the University of Paris, Yale Professor Leonid Glazman has developed a theoretical framework for better understanding the properties of electric charge in nanoscale devices.
The CEID was bustling with activity this summer, as teams of engineering students developed innovative devices to combat real-world problems. One such invention was Acantha, a one-handed catheter delivery system developed by Yale engineering students Brandon Hudik and Andres Ornelas Vargas. This duo is continuing their work beyond their eight-week fellowship at the CEID and plan to scale up the development of their product.
Alive or dead? Cutting-edge research by scientists at Yale multiplies the power of Schrodinger’s cat, heralding the age of the quantum computer.
The Yale Cancer Biology Institute on West Campus is now the nexus of a new initiative geared towards understanding the dynamic changes in cell behavior that characterize cancer. The Institute, together with its collaborators, was the recipient of a 9.5 million dollar grant from the NIH; the funding may pave the way for more advanced therapies that target metastatic cells.